Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D5GG
|
|||
| Former ID |
DIB012469
|
|||
| Drug Name |
Pemoline
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H8N2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2C(=O)N=C(O2)N
|
|||
| InChI |
1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)
|
|||
| InChIKey |
NRNCYVBFPDDJNE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2152-34-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:7953
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.